Revenue
2018
2019
2020
2021
2022
2023
2024
2025
IMMUCELL CORP /DE/ (ICCC)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.6M | $26.5M | $17.5M | $18.6M | $19.2M | $15.3M | $13.7M | $11.0M | $10.4M | — | — | — | — | — | — | — | — |
| Gross profit | $11.4M | $7.9M | $3.9M | $7.6M | $8.7M | $6.9M | $6.7M | $5.2M | $5.2M | $5.4M | $6.3M | $4.4M | $3.1M | $3.1M | $2.8M | $2.3M | $2.4M |
| Research & development | $3.0M | $3.9M | $4.4M | $4.5M | $4.2M | $4.4M | $3.7M | $3.5M | $2.0M | $1.2M | $1.2M | $2.2M | $1.2M | $917,600 | $1.7M | $1.5M | $1.6M |
| Operating expenses | $9.8M | $9.6M | $9.6M | $9.9M | $8.4M | $8.2M | $7.7M | $6.6M | $5.5M | $4.5M | $4.1M | $4.7M | $3.1M | $2.8M | $3.4M | $3.0M | $2.9M |
| Operating income | $1.6M | −$1.6M | −$5.7M | −$2.3M | $257,385 | −$1.4M | −$953,908 | −$1.4M | −$242,845 | $890,204 | $2.1M | −$206,398 | −$19,552 | $245,001 | −$632,726 | −$690,281 | −$529,914 |
| EBITDAderived | $4.4M | $1.1M | −$3.0M | $188,640 | $2.7M | $966,930 | $1.3M | $74,141 | $661,590 | $1.7M | — | — | — | — | — | — | — |
| Net income | −$1.0M | −$2.2M | −$5.8M | −$2.5M | −$78,292 | −$1.0M | −$1.3M | −$2.3M | −$168,147 | $508,448 | $1.2M | −$167,159 | $117,395 | $89,512 | −$409,510 | −$384,684 | −$216,493 |
| Basic EPSper diluted share | -$0.12 | -$0.26 | -$0.75 | -$0.32 | -$0.01 | -$0.14 | -$0.19 | -$0.42 | -$0.03 | $0.12 | $0.40 | -$0.06 | $0.04 | $0.03 | -$0.14 | -$0.13 | -$0.07 |
| Diluted EPSper diluted share | -$0.12 | -$0.26 | -$0.75 | -$0.32 | -$0.01 | -$0.14 | -$0.19 | -$0.42 | -$0.03 | $0.12 | $0.38 | -$0.06 | $0.04 | $0.03 | -$0.14 | -$0.13 | -$0.07 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 18, 2026Form 4 | te Boekhorst Paul Francis OlivierPresident and CEO | BuyCommon Stock, par value $.01 per share | 8.0K | $9.50 | $76.0K | 17.8K |
| Dec 4, 2025Form 4/A | te Boekhorst Paul Francis OlivierPresident and CEO | BuyCommon Stock $0.10 par value per share | 2.4K | $5.50 | $13.4K | 9.7K |
| Dec 3, 2025Form 4/A | te Boekhorst Paul Francis OlivierPresident and CEO | BuyCommon Stock $0.10 par value per share | 3.6K | $5.05 | $18.2K | 7.3K |
| Dec 3, 2025Form 4 | te Boekhorst Paul Francis OlivierPresident and CEO | BuyCommon Stock $0.10 par value per share | 3.5K | $5.04 | $17.7K | 9.8K |
| Dec 3, 2025Form 4 | te Boekhorst Paul Francis OlivierPresident and CEO | BuyCommon Stock $0.10 par value per share | 2.6K | $5.00 | $12.8K | 6.3K |